Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
- PMID: 11331884
- DOI: 10.1038/35074604
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Abstract
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation. However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation or to transform rodent fibroblasts, indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
Similar articles
-
Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.Mol Cell Biol. 2001 Nov;21(21):7429-41. doi: 10.1128/MCB.21.21.7429-7441.2001. Mol Cell Biol. 2001. PMID: 11585923 Free PMC article.
-
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.Nat Cell Biol. 2003 May;5(5):427-32. doi: 10.1038/ncb978. Nat Cell Biol. 2003. PMID: 12717443
-
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.Mol Cancer Res. 2002 Nov;1(1):2-11. Mol Cancer Res. 2002. PMID: 12496364
-
Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling.Cell Biochem Biophys. 1999;30(3):369-87. doi: 10.1007/BF02738120. Cell Biochem Biophys. 1999. PMID: 10403057 Review.
-
Signal transfer by Eph receptors.Cell Tissue Res. 1999 Oct;298(1):1-9. Cell Tissue Res. 1999. PMID: 10555534 Review.
Cited by
-
Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.PLoS One. 2013 May 22;8(5):e65005. doi: 10.1371/journal.pone.0065005. Print 2013. PLoS One. 2013. PMID: 23717685 Free PMC article.
-
A systems biology approach to the global analysis of transcription factors in colorectal cancer.BMC Cancer. 2012 Aug 1;12:331. doi: 10.1186/1471-2407-12-331. BMC Cancer. 2012. PMID: 22852817 Free PMC article.
-
EphA2 silencing promotes growth, migration, and metastasis in salivary adenoid cystic carcinoma: in vitro and in vivo study.Am J Transl Res. 2016 Mar 15;8(3):1518-29. eCollection 2016. Am J Transl Res. 2016. PMID: 27186278 Free PMC article.
-
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer.Clin Exp Metastasis. 2003;20(1):59-68. doi: 10.1023/a:1022546620495. Clin Exp Metastasis. 2003. PMID: 12650608 Review.
-
EphB6 crosslinking results in costimulation of T cells.J Clin Invest. 2002 Oct;110(8):1141-50. doi: 10.1172/JCI15883. J Clin Invest. 2002. PMID: 12393850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous